课题基金 / 基金详情

CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H

CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H
盐酸米多君对神经源性直立性 H 患者的临床益处
批准号：
6265062
负责人：
DANIEL BLOOMFIELD
金额：
$0.04万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6265062
关键词：
clinical research drug screening /evaluation ethanolamines human subject human therapy evaluation postural hypotension quality of life

项目摘要

项目成果

DANIEL BLOOMFIELD的其他基金

相关文献

中文摘要
翻译
这项多中心、随机、双盲研究希望确定米多君对神经源性直立性低血压患者的临床益处。主要的假设是米多君通过使患者能够进行日常生活活动来提高生活质量。
英文摘要
This multicenter, randomized,double-blind study hopes to define the clinical benefit of midodrine in patients with neurogenic orthostatic hypotension. The primary hypothesis is that midodrine improve qualitiy of life by enabling patients to pursue activities of daily living.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF T WAVE ALTERNANS IN SEVERE CHF
CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H
PREVALENCE AND PROGNOSTIC SIGNIFICANCE OF T WAVE ALTERNANS IN SEVERE CHF
CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H